Regulus Therapeutics Inc (NASDAQ:RGLS)

Delayed Data
As of Nov 26
 +0.0222 / +5.66%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 1.00, with a high estimate of 2.00 and a low estimate of 0.50. The median estimate represents a +141.43% increase from the last price of 0.41.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Regulus Therapeutics Inc. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.67%
Growthannually 23.70%


Growthquarterly --
Growthannually -99.94%
Key to the earnings and sales forecast charts.